Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su Han Lum

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal of Clinical Immunology|July 14, 2023
Outcome of Second Allogeneic HSCT for Patients with Inborn Errors of Immunity: Retrospective Study of 20 Years' ExperiencePriti Mehta, Christo Tsilifis, Su Han Lum, et al.
Blood|April 7, 2019
Two decades of excellent transplant survival for chronic granulomatous disease: a supraregional immunology transplant center reportSu Han Lum, Terence Flood, Sophie Hambleton, et al.
Pediatric Blood & Cancer|July 16, 2024
CD3<sup>+</sup>TCRαβ/CD19<sup>+</sup>-depleted stem cell boost and CD45RO<sup>+</sup> memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCTSubramaniam Ramanathan, Wing Roberts, Zohreh Nademi, et al.
Transplantation and Cellular Therapy|June 6, 2023
CD3Subramaniam Ramanathan, Su Han Lum, Zohreh Nademi, et al.
Journal of Clinical Immunology|March 15, 2022
Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency-Improved Outcomes in the Modern EraElisabetta Ghimenton, Aisling Flinn, Su Han Lum, et al.
JIMD Reports|December 8, 2017
Haematopoietic Stem Cell Transplantation Arrests the Progression of Neurodegenerative Disease in Late-Onset Tay-Sachs DiseaseKarolina M Stepien, Su Han Lum, J Edmond Wraith, et al.
Pediatric Blood & Cancer|August 11, 2022
Allogenic haematopoeitic stem cell transplant as cure for severe transfusion-dependent non-dominant hereditary spherocytosis due to homozygous SPTA1 mutationSubramaniam Ramanathan, Wing Roberts, Peter Carey, et al.
Journal of Clinical Immunology|March 19, 2022
TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined ImmunodeficiencyChristo Tsilifis, Su Han Lum, Zohreh Nademi, et al.
British Journal of Haematology|June 2, 2025
Low rates of endothelial cell dysfunction and transplant-related mortality in 537 children receiving fludarabine-treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the UK Paediatric BMT groupThomas Altmann, Kanchan Rao, Ramya Hanasoge-Nataraj, et al.
Journal of Paediatrics and Child Health|September 4, 2019
Haematopoietic stem cell transplantation for inborn errors of immunity: 25-year experience from University of Malaya Medical Centre, MalaysiaHany Ariffin, Syaza Ab Rahman, Vida Jawin, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Immunology|July 14, 2023
Outcome of Second Allogeneic HSCT for Patients with Inborn Errors of Immunity: Retrospective Study of 20 Years' ExperiencePriti Mehta, Christo Tsilifis, Su Han Lum, et al.
Blood|April 7, 2019
Two decades of excellent transplant survival for chronic granulomatous disease: a supraregional immunology transplant center reportSu Han Lum, Terence Flood, Sophie Hambleton, et al.
Pediatric Blood & Cancer|July 16, 2024
CD3<sup>+</sup>TCRαβ/CD19<sup>+</sup>-depleted stem cell boost and CD45RO<sup>+</sup> memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCTSubramaniam Ramanathan, Wing Roberts, Zohreh Nademi, et al.
Transplantation and Cellular Therapy|June 6, 2023
CD3Subramaniam Ramanathan, Su Han Lum, Zohreh Nademi, et al.
Journal of Clinical Immunology|March 15, 2022
Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency-Improved Outcomes in the Modern EraElisabetta Ghimenton, Aisling Flinn, Su Han Lum, et al.
JIMD Reports|December 8, 2017
Haematopoietic Stem Cell Transplantation Arrests the Progression of Neurodegenerative Disease in Late-Onset Tay-Sachs DiseaseKarolina M Stepien, Su Han Lum, J Edmond Wraith, et al.
Pediatric Blood & Cancer|August 11, 2022
Allogenic haematopoeitic stem cell transplant as cure for severe transfusion-dependent non-dominant hereditary spherocytosis due to homozygous SPTA1 mutationSubramaniam Ramanathan, Wing Roberts, Peter Carey, et al.
Journal of Clinical Immunology|March 19, 2022
TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined ImmunodeficiencyChristo Tsilifis, Su Han Lum, Zohreh Nademi, et al.
British Journal of Haematology|June 2, 2025
Low rates of endothelial cell dysfunction and transplant-related mortality in 537 children receiving fludarabine-treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the UK Paediatric BMT groupThomas Altmann, Kanchan Rao, Ramya Hanasoge-Nataraj, et al.
Journal of Paediatrics and Child Health|September 4, 2019
Haematopoietic stem cell transplantation for inborn errors of immunity: 25-year experience from University of Malaya Medical Centre, MalaysiaHany Ariffin, Syaza Ab Rahman, Vida Jawin, et al.
Pageof 6